Zhao M, Hagler H K, Muntz K H
Department of Cell Biology and Neuroscience, University of Texas Southwestern Medical Center at Dallas 75235-9039, USA.
Am J Physiol. 1996 Nov;271(5 Pt 2):H1762-8. doi: 10.1152/ajpheart.1996.271.5.H1762.
Previous studies suggest that the desensitization and downregulation of beta 1-adrenergic receptors (beta 1-AR) in the failing heart are the result of the elevated plasma catecholamine levels associated with this disease. To examine norepinephrine (NE)-induced regulation of cardiac adrenergic receptors, rats were infused with l-NE (200 micrograms.kg-1.h-1 for 7 days) or vehicle (0.001 N HCl) by implantation of osmotic minipumps. The technique of coverslip autoradiography was used to quantify alpha 1-adrenergic receptors (alpha 1-AR), beta 1-AR, and beta 2-AR in different tissue compartments of rat hearts. For measurement of beta-AR binding, sections were incubated with 70 pM [125I]iodocyanopindolol (ICYP) alone or in the presence of 5 microM dl-propranolol or 5 x 10(-7) M CGP-20712A (a beta 1-antagonist) and then set up for autoradiography. [3H]prazosin (1 nM) with or without phentolamine was used to study alpha-AR binding. Chronic infusion of NE induced a greater downregulation of beta 2-AR compared with beta 1-AR in all regions studied, including atrial and ventricular myocytes, coronary arterioles, and connective tissue. An 18% loss of beta 1-AR was seen only in atrial myocytes; beta 1-AR density actually increased 28% in ventricular myocytes following NE infusion. There was a 15% decrease in alpha 1-AR in ventricular myocytes, whereas no change in alpha 1-AR density was seen in myocardial arterioles. Our study demonstrates that beta 2-AR are more susceptible to NE-induced downregulation than beta 1-AR. Thus other mechanisms may be involved in the selective downregulation of beta 1-AR in certain forms of heart failure.
先前的研究表明,衰竭心脏中β1-肾上腺素能受体(β1-AR)的脱敏和下调是与该疾病相关的血浆儿茶酚胺水平升高的结果。为了研究去甲肾上腺素(NE)诱导的心脏肾上腺素能受体调节,通过植入渗透微型泵给大鼠输注左旋去甲肾上腺素(200微克·千克-1·小时-1,持续7天)或载体(0.001N盐酸)。采用盖玻片放射自显影技术对大鼠心脏不同组织区域的α1-肾上腺素能受体(α1-AR)、β1-AR和β2-AR进行定量。为了测量β-AR结合,将切片单独与70pM[125I]碘氰吲哚洛尔(ICYP)孵育,或在5μM二氯异丙肾上腺素或5×10-7M CGP-20712A(一种β1拮抗剂)存在的情况下孵育,然后进行放射自显影。[3H]哌唑嗪(1nM)在有或没有酚妥拉明的情况下用于研究α-AR结合。与β1-AR相比,在所有研究区域,包括心房和心室肌细胞、冠状动脉小动脉和结缔组织中,慢性输注NE诱导的β2-AR下调程度更大。仅在心房肌细胞中观察到β1-AR减少18%;NE输注后心室肌细胞中β1-AR密度实际上增加了28%。心室肌细胞中α1-AR减少了15%,而心肌小动脉中α1-AR密度没有变化。我们的研究表明,β2-AR比β1-AR更容易受到NE诱导的下调影响。因此,在某些形式的心力衰竭中,β1-AR的选择性下调可能涉及其他机制。